Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.165
+0.095 (8.88%)
Jun 6, 2025, 2:52 PM - Market open
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $70.57 million as of June 6, 2025. Its market cap has decreased by -69.41% in one year.
Market Cap
70.57M
Enterprise Value
-103.35M
1-Year Change
-69.41%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $70.57M, a decrease of -88.59%. That is a compound annual growth rate of -42.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 64.81M | -37.28% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.00B |
| Johnson & Johnson | 371.55B |
| AbbVie | 330.76B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 273.25B |
| Abbott Laboratories | 232.63B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |